Martina Brucoli

Martina Brucoli

Auto-generated profile, based on publicly available information

Martina Brucoli

Tumour Cell Death and Autophagy Laboratory, Cancer Research UK Scotland Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
VBValentin Barthet
Valentin Barthet
MBMartina Brucoli
Martina Brucoli
MLMarcus J. G. W. Ladds
Marcus J. G. W. Ladds
CNChristoph Nössing
Christoph Nössing
CKChristos Kiourtis
Christos Kiourtis
KRKevin M. Ryan
Kevin M. Ryan
Autophagy represses YAP/TAZ-dependent hepatocyte dedifferentiation into liver progenitor cells to prevent tumorigenesis.

6 July 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JLJaclyn S. Long
Jaclyn S. Long
EKElżbieta Kania
Elżbieta Kania
DMDavid G. McEwan
David G. McEwan
VBValentin Barthet
Valentin Barthet
MBMartina Brucoli
Martina Brucoli
KRKevin M. Ryan
Kevin M. Ryan
The role of autophagy in cancer is complex. Both tumor-promoting and tumor-suppressive effects are reported, with tumor type, stage and specific genetic lesions dictating the role. This calls for analysis in models that best recapitulate each tumor type, from initiation to metastatic disease, to specifically understand the contribution of autophagy in each context. Here, we report the effects of deleting the essential autophagy gene Atg7 in a model of pancreatic ductal adenocarcinoma (PDAC), in which mutant Kras G12D and mutant Trp53 172H are induced in adult tissue leading to metastatic PDAC. This revealed that Atg7 loss in the presence of Kras G12D /+ and Trp53 172H /+ was tumor promoting, similar to previous observations in tumors driven by embryonic Kras G12D /+ and deletion of Trp53 . However, Atg7 hemizygosity also enhanced tumor initiation and progression, even though this did not ablate autophagy. Moreover, despite this enhanced progression, fewer Atg7 hemizygous mice had metastases compared with animals wild type for this allele, indicating that ATG7 is a promoter of metastasis. We show, in addition, that Atg7 +/− tumors have comparatively lower levels of succinate, and that cells derived from Atg7 +/− tumors are also less invasive than those from Atg7 +/+ tumors. This effect on invasion can be rescued by ectopic expression of Atg7 in Atg7 +/− cells, without affecting the autophagic capacity of the cells, or by treatment with a cell-permeable analog of succinate. These findings therefore show that ATG7 has roles in invasion and metastasis that are not related to the role of the protein in the regulation of autophagy.

7 April 2026 in Molecular Cell
Verified
Journal Article
Open access
CNChristoph Nössing
Christoph Nössing
OTOlga Troitskaya
Olga Troitskaya
JLJaclyn S. Long
Jaclyn S. Long
ACAndrew Craxton
Andrew Craxton
MBMartina Brucoli
Martina Brucoli
KRKevin M. Ryan
Kevin M. Ryan
Inflammation can affect many diseases. We report here that inflammatory cytokines invoke caspase-8-mediated cleavage of the autophagy adaptor p62/SQSTM1 at aspartic acid 329 in human cells, producing a previously described truncated form, which we term tr-p62. We show that TNF-driven cell death is tr-p62 dependent and that autophagy inhibition promotes death via tr-p62 accumulation. Mechanistically, p62 cleavage is receptor-interacting serine/threonine-protein kinase 1 (RIPK1) dependent, and tr-p62 stabilizes caspase-8 activating complex-IIb. tr-p62-driven cell death downstream of TNF is also RIPK1 and caspase dependent, promoting feedforward caspase-8 activation. p62 cleavage does not, however, affect necroptosis. Surprisingly, this caspase-8 cleavage site in p62 is absent in mice, and introduction of cleavable forms of p62 into mouse cells causes sensitization to TNF-induced death. Moreover, mice with CRISPR-Cas9-generated cleavable p62 exhibit TNF hypersensitivity and intestinal inflammation in vivo. These findings provide significant insights into TNF-induced cell death and introduce a mouse model that may provide better clarity for human-related studies of inflammatory disease.